U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07735650) titled 'Immunosuppressant Withdrawal Based on Parenchymal Chimerism in the Liver Transplantation' on Dec. 03, 2025.
Brief Summary: The goal of this clinical trial is to learn whether liver parenchyma chimerism can represent a chievement of operational tolerance in liver transplantation recipients. The researchers will examine the degree of parenchyma chimerism. The participants will withdraw or minimize their immunosuppression to avoid the adverse effects of immunosuppressants.
Study Start Date: Aug. 01, 2025
Study Type: INTERVENTIONAL
Condition:
Liver Transplantation
Liver Transplantation in Long-term
Intervention:
PROCEDURE: liver b...